Francisco Campello do Amaral Mello
Overview
Explore the profile of Francisco Campello do Amaral Mello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lago B, Portilho M, Mello V, De Sousa P, Angelice G, Marques B, et al.
Sci Rep
. 2024 May;
14(1):10742.
PMID: 38730249
The selection pressure imposed by the host immune system impacts on hepatitis B virus (HBV) variability. This study evaluates HBV genetic diversity, nucleos(t)ide analogs resistance and HBsAg escape mutations in...
2.
Villar L, da Silva L, do Lago B, Pereira J, Guimaraes A, Mello F, et al.
Expert Rev Anti Infect Ther
. 2024 Jan;
22(1-3):5-17.
PMID: 38224018
Introduction: Severe acute hepatitis (SAH) is defined by a severe inflammation of hepatocytes in the liver parenchyma which can lead to an acute liver failure, a clinical condition with high...
3.
Villar L, Fraga K, Mendonca A, Miguel J, Silva E, Barbosa J, et al.
Braz J Infect Dis
. 2022 Jun;
26(3):102371.
PMID: 35661641
Chronic kidney disease (CKD) patients undergoing hemodialysis (HD) are more vulnerable to blood-borne viral infections due to frequent invasive procedures. Hepatitis B virus (HBV) infection in this cohort of patients...
4.
da Cruz J, Villar L, Mello F, Lampe E, Hyppolito E, de Castro Lima J, et al.
Rev Soc Bras Med Trop
. 2021 Sep;
54:e08072020.
PMID: 34495262
Introduction: Hepatitis B virus (HBV) infection is a public health problem; therefore, we aimed to report HBV genotypes in Ceará, Brazil. Methods: A total of 103 HBsAg-positive samples were subjected...
5.
de Pina-Araujo I, Horta M, Mello F, Soares C
Arch Virol
. 2021 Mar;
166(5):1345-1353.
PMID: 33689039
Human pegivirus 1 (HPgV-1) belongs to the genus Pegivirus, family Flaviviridae, and until now has been considered a non-pathogenic agent, despite being considered a risk factor for non-Hodgkin lymphoma. However,...
6.
Antonio Ferreira-Junior P, de-Oliveira E, Martin T, Rodrigues Alves-Junior E, Silva L, Mello F, et al.
Rev Soc Bras Med Trop
. 2020 Oct;
53:e20190559.
PMID: 33111905
Introduction: Brazil's western Amazon basin has the highest prevalence of hepatitis B virus (HBV) infection in the country. Coinfection with hepatitis D virus (HDV) is also endemic. To estimate the...
7.
Hebeler-Barbosa F, Wolf I, Valente G, Mello F, Lampe E, de Moura Campos Pardini M, et al.
Microorganisms
. 2020 Sep;
8(9).
PMID: 32932752
Hepatitis B virus (HBV) is an enveloped virus that induces chronic liver disease. HBV has been classified into eight genotypes (A-H) according to its genome sequence by using Sanger sequencing...
8.
Cantelli C, Velloso A, de Assis R, Barros J, Mello F, Cunha D, et al.
Sci Rep
. 2020 Apr;
10(1):6965.
PMID: 32332841
Recent studies have investigated whether the human histo-blood group antigen (HBGAs) could affect the effectiveness of the oral rotavirus vaccines, suggesting secretor positive individuals develop a more robust response. We...
9.
Costa V, Brandao-Mello C, Nunes E, Dos Santos Silva P, de Souza Rodrigues L, Lampe E, et al.
PLoS One
. 2019 May;
14(5):e0216327.
PMID: 31063475
The selection of viral strains with resistance-associated substitutions at hepatitis C virus (HCV) NS5A and NS5B genes is considered one of the limiting factors for achieving sustained virologic response (SVR)...
10.
Costa V, Delvaux N, Brandao-Mello C, Nunes E, De Sousa P, de Souza Rodrigues L, et al.
Clin Res Hepatol Gastroenterol
. 2019 Mar;
43(6):700-706.
PMID: 30880098
Background And Aims: Treatment for hepatitis C has evolved significantly with the licensing of direct-acting antiviral drugs (DAAs). However, one of the limiting factors of the effectiveness of antiviral therapy...